ANDAs: Pre-Submission of Facility Information Related to Prioritized Generic Drug Applications

USA – Evidentiary Expectations for 510(k) Implant Devices

As part of FDA’s Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health (herein referred to as the “Safety Action Plan”), FDA committed to...

USA – Best Practices for Selecting a Predicate Device to Support a Premarket Notification...

FDA developed this document to provide guidance to industry and FDA staff about best practices in selecting a predicate device for premarket notification ...
Australian regulatory action on breast implants and breast tissue expanders

Australia – Medical devices vigilance program pilot

The TGA is commencing a new Medical Devices Vigilance Program (MDVP). The MDVP will begin as a 12-month pilot. The pilot is designed to...

USA – FDA finalizes guidance on use of human factors studies in combination product...

The US Food and Drug Administration (FDA) finalized its guidance for industry on the use of human factors engineering (HFE) studies to support the...

USA – FDA updates off-the-shelf software guidance to reflect least burdensome approach

The US Food and Drug Administration (FDA) has reissued a final guidance on off-the-shelf (OTS) software used by medical devices, which aims to reduce...

USA – FDA details proposed 510(k) modernization with trio of draft guidances

The US Food and Drug Administration (FDA) has announced new steps it is taking to modernize the 510(k) program, which include updates on its...
Drugmakers Make Significant Headway in Track-and-Trace Compliance

International – E-labeling and digital transformation in healthcare

This article examines the regulations for electronic labeling (e-labeling) for prescription drugs and medical devices in Japan, Brazil, Singapore, the EU and US, Canada,...

Europe – Evaluation clinique : retours d’expérience d’un organisme notifié

Avec le Règlement (UE) 2017/745 sur les dispositifs médicaux (RDM), l’évaluation clinique est devenue une étape centrale dans l’évaluation de la conformité des produits,...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Three new UK Approved Bodies to certify medical devices announced by the...

TÜV SÜD, Intertek, and TÜV Rheinland UK join the four current UK Approved Bodies, almost doubling current capacity for the certification of medical devices...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical devices: UK approved bodies

UK approved bodies listed under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002)...

NOS PROCHAINES FORMATIONS